The MedicX Fund Limited Board change (5980X)

TIDMMXF

RNS Number : 5980X

The MedicX Fund Limited

22 February 2017

Press Release

For immediate release

22 February 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Board change

MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, today announces the appointment of Helen Mahy to the Board as a non-executive director with effect from 1 April 2017.

Helen is chairman of The Renewables Infrastructure Group Limited, a FTSE 250 investment company, and is a non-executive director of SSE plc and of SVG Capital plc, each listed on the London Stock Exchange, and of Bonheur ASA, a company listed on the Oslo Stock Exchange. Helen qualified as a barrister and was an Associate of the Chartered Insurance Institute. In 2015 she was awarded a CBE for services to business and voluntary service, particularly to the legal profession and diversity in the workplace. Helen was formerly Group Company Secretary and General Counsel of National Grid plc until she retired in 2013.

David Staples, Chairman of MedicX Fund, commented:

"As I explained in my Chairman's Statement in our Annual Report published in December, the Board is working through its succession plans. In line with those plans, we are delighted to welcome Helen to the Board. Her expertise in legal matters and corporate governance, together with her experience in the infrastructure sector, will be of great benefit to the Company and the Board."

There is no further information to be disclosed under Listing Rule 9.6.13R.

End

For further information please contact:

MedicX Fund [phone]

David Staples, Chairman

Octopus Healthcare Group [phone]

Mike Adams, Chief Executive Officer

Canaccord Genuity

   Andrew Zychowski/Helen Goldsmith                                             [phone] 

Buchanan [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 152 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP6 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAUUVNRBBAUUAR

(END) Dow Jones Newswires

February 22, 2017 12:00 ET (17:00 GMT)